BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37005497)

  • 1. Involvement of matrix metalloproteinase 1 and urokinase-type plasminogen activator in the PKCα-p38 MAPK pathway-mediated progression of human liver cancer cells.
    Ye JC; Hsieh YS; Chen PN; Liu JY; Hsieh YH
    Drug Dev Res; 2023 Jun; 84(4):767-776. PubMed ID: 37005497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells.
    Hsieh YH; Wu TT; Huang CY; Hsieh YS; Hwang JM; Liu JY
    Cancer Res; 2007 May; 67(9):4320-7. PubMed ID: 17483345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
    J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acacetin, a flavonoid, inhibits the invasion and migration of human prostate cancer DU145 cells via inactivation of the p38 MAPK signaling pathway.
    Shen KH; Hung SH; Yin LT; Huang CS; Chao CH; Liu CL; Shih YW
    Mol Cell Biochem; 2010 Jan; 333(1-2):279-91. PubMed ID: 19693651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of p38 MAPK in gastrin-induced u-PA expression in human colon cancer cells].
    Ming M; Yu JP; Zhou YH; Cao J; Song WC; Yu HG; Luo HS
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):4-8. PubMed ID: 17575684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of urokinase-type plasminogen activator and inhibitor and gelatinase expression via 3 mitogen-activated protein kinases and PI3K pathways during the early development of osteoarthritis.
    Hsieh YS; Yang SF; Lue KH; Chu SC; Li TJ; Lu KH
    J Rheumatol; 2007 Apr; 34(4):785-93. PubMed ID: 17299841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of urokinase plasminogen activator and matrix metalloproteinases and up-regulation of their inhibitors by a novel nutrient mixture in human prostate cancer cell lines PC-3 and DU-145.
    Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
    Oncol Rep; 2011 Dec; 26(6):1407-13. PubMed ID: 21874261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human lung cancer and mesothelioma cell lines.
    Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
    Int J Oncol; 2013 Jun; 42(6):1883-9. PubMed ID: 23563849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin/Matrix Metalloproteinase-9-Dependent SK-N-SH Cell Migration is Mediated Through a PLC/PKC/MAPKs/NF-κB Cascade.
    Yang CC; Lin CC; Chien PT; Hsiao LD; Yang CM
    Mol Neurobiol; 2016 Nov; 53(9):5833-5846. PubMed ID: 26497035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines.
    Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
    Oncol Rep; 2012 Sep; 28(3):768-76. PubMed ID: 22736175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JNK suppression is essential for 17β-Estradiol inhibits prostaglandin E2-Induced uPA and MMP-9 expressions and cell migration in human LoVo colon cancer cells.
    Hsu HH; Hu WS; Lin YM; Kuo WW; Chen LM; Chen WK; Hwang JM; Tsai FJ; Liu CJ; Huang CY
    J Biomed Sci; 2011 Aug; 18(1):61. PubMed ID: 21859479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation.
    Cortez DM; Feldman MD; Mummidi S; Valente AJ; Steffensen B; Vincenti M; Barnes JL; Chandrasekar B
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3356-65. PubMed ID: 17921324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells.
    Gomes LR; Terra LF; Wailemann RA; Labriola L; Sogayar MC
    BMC Cancer; 2012 Jan; 12():26. PubMed ID: 22260435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines.
    Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
    Int J Oncol; 2013 Jul; 43(1):39-49. PubMed ID: 23661254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of p38 MAPK.
    Hecht M; Heider U; Kaiser M; von Metzler I; Sterz J; Sezer O
    Br J Haematol; 2007 Aug; 138(4):446-58. PubMed ID: 17593251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways.
    Liu SQ; Huang JA; Qin MB; Su YJ; Lai MY; Jiang HX; Tang GD
    Int J Colorectal Dis; 2012 Dec; 27(12):1569-78. PubMed ID: 22684547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells.
    Han Q; Leng J; Bian D; Mahanivong C; Carpenter KA; Pan ZK; Han J; Huang S
    J Biol Chem; 2002 Dec; 277(50):48379-85. PubMed ID: 12377770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of lipopolysaccharide-induced monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases.
    Lai WC; Zhou M; Shankavaram U; Peng G; Wahl LM
    J Immunol; 2003 Jun; 170(12):6244-9. PubMed ID: 12794156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dioscorea nipponica Attenuates Migration and Invasion by Inhibition of Urokinase-Type Plasminogen Activator through Involving PI3K/Akt and Transcriptional Inhibition of NF-[Formula: see text]B and SP-1 in Hepatocellular Carcinoma.
    Hsieh MJ; Yeh CB; Chiou HL; Hsieh MC; Yang SF
    Am J Chin Med; 2016; 44(1):177-95. PubMed ID: 26916922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-metastatic potential of a proton beam is regulated by p38 MAPK/c-Fos signaling pathway in TPA-treated HepG2 human hepatocellular carcinoma.
    Chun SY; Kim S; Nam KS; Lee KS
    Biomed Pharmacother; 2018 Mar; 99():904-912. PubMed ID: 29710490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.